Regulation of miRNAs by agents targeting the tumor stem cell markers DCLK1, MSI1, LGR5, and BMI1.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 26366338)

Published in Curr Pharmacol Rep on August 01, 2015

Authors

Sripathi M Sureban1, Dongfeng Qu1, Courtney W Houchen1

Author Affiliations

1: Department of Internal Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK 73104 ; Department of Veterans Affairs Medical Center, Oklahoma City, OK 73104 ; Peggy and Charles Stephenson Oklahoma Cancer Center, Oklahoma City, OK 73104 Phone number: (405) 271-2175/fax number: (405) 271-5450.

Articles cited by this

Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57

A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26

RAS is regulated by the let-7 microRNA family. Cell (2005) 30.24

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell (2006) 23.59

MicroRNA maturation: stepwise processing and subcellular localization. EMBO J (2002) 19.47

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 18.86

Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42

Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res (2003) 17.13

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008) 15.01

Processing of primary microRNAs by the Microprocessor complex. Nature (2004) 14.59

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell (2006) 11.01

Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet (2008) 10.22

Cancer stem cells. N Engl J Med (2006) 9.63

Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol (2007) 4.12

Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle (2009) 3.68

MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics (2010) 2.80

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol (2007) 2.80

A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther (2009) 2.61

Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci (2007) 2.61

EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. Cancer Cell (2012) 2.59

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev (2010) 2.37

Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet (2012) 2.33

DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology (2013) 2.26

Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol (2008) 2.18

Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst (2006) 2.10

Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem (2011) 1.94

Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol Cancer Ther (2011) 1.76

DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res (2011) 1.73

Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol (2006) 1.72

Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One (2011) 1.55

Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism. Gastroenterology (2009) 1.53

MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol (2011) 1.42

Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Med (2012) 1.35

Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas. Am J Physiol Gastrointest Liver Physiol (2010) 1.28

On the genesis and regulation of cellular heterogeneity in malignant tumors. Invasion Metastasis (1982) 1.25

Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shanghai) (2009) 1.20

EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res (2011) 1.18

DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer. PLoS One (2013) 1.17

Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells. PLoS One (2012) 1.10

XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism. Cancer Lett (2014) 1.08

Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1. Mol Cancer (2014) 0.99

Colorectal cancer in review: the role of the EGFR pathway. Expert Opin Investig Drugs (2010) 0.99

The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs. RNA Biol (2011) 0.98

Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype. Int J Oncol (2011) 0.96

Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism: network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescence. Semin Cancer Biol (2014) 0.96

Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells. Biochem Biophys Res Commun (2013) 0.95

Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA. Cancer Res (2014) 0.93

Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma. Oncogene (2013) 0.92

Ready, set, go: the EGF receptor at the pancreatic cancer starting line. Cancer Cell (2012) 0.91

A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells. PLoS One (2013) 0.88

CD24 can be used to isolate Lgr5+ putative colonic epithelial stem cells in mice. Am J Physiol Gastrointest Liver Physiol (2012) 0.87

The Role of EMT in Pancreatic Cancer Progression. Pancreat Disord Ther (2012) 0.85

Activation of apoptosis by 1-hydroxy-5,7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos. Cancer Res (2008) 0.85